Skip to main content
. 1997 May 27;94(11):5810–5813. doi: 10.1073/pnas.94.11.5810

Figure 1.

Figure 1

Tumor volumes in athymic nude mice bearing subcutaneously xenografted Caki-I carcinomas during treatment with the GH-RH antagonist MZ-4-71 administered at a dose of 20 μg B.I.D. per animal, s.c. Treatment was started when the tumors measured approximately 24–27 mm3 and lasted for 4 weeks. Vertical bars represent standard error, ∗, P < 0.5 versus control, ∗∗, P < 0.01 versus control.